Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
CELZ price, last 12 months
Key stats
- Previous close
- $0.9700
- Open
- $0.9902
- Day range
- $0.9420 – $1.05
- 52-week range
- $0.6200 – $6.25
- Volume
- 323.7K
- Avg volume (20 days)
- 1.3M
- Market cap
- $6.8M
Performance
Technicals and fundamentals
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $6.8M